"Secondary Prevention" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The prevention of recurrences or exacerbations of a disease or complications of its therapy.
| Descriptor ID |
D055502
|
| MeSH Number(s) |
E02.897 N02.421.726.825 N06.850.780.750
|
| Concept/Terms |
Secondary Prevention- Secondary Prevention
- Prevention, Secondary
- Preventions, Secondary
- Secondary Preventions
- Secondary Disease Prevention
- Disease Prevention, Secondary
- Disease Preventions, Secondary
- Prevention, Secondary Disease
- Preventions, Secondary Disease
- Secondary Disease Preventions
Relapse Prevention- Relapse Prevention
- Prevention, Relapse
- Preventions, Relapse
- Relapse Preventions
Early Therapy- Early Therapy
- Early Therapies
- Therapies, Early
- Therapy, Early
|
Below are MeSH descriptors whose meaning is more general than "Secondary Prevention".
Below are MeSH descriptors whose meaning is more specific than "Secondary Prevention".
This graph shows the total number of publications written about "Secondary Prevention" by people in this website by year, and whether "Secondary Prevention" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 0 | 1 | 1 |
| 2000 | 0 | 4 | 4 |
| 2001 | 0 | 2 | 2 |
| 2002 | 0 | 5 | 5 |
| 2003 | 0 | 7 | 7 |
| 2004 | 0 | 3 | 3 |
| 2005 | 1 | 4 | 5 |
| 2006 | 0 | 7 | 7 |
| 2007 | 0 | 4 | 4 |
| 2008 | 1 | 6 | 7 |
| 2009 | 1 | 7 | 8 |
| 2010 | 0 | 7 | 7 |
| 2011 | 3 | 11 | 14 |
| 2012 | 2 | 4 | 6 |
| 2013 | 2 | 8 | 10 |
| 2014 | 1 | 4 | 5 |
| 2015 | 2 | 0 | 2 |
| 2016 | 4 | 3 | 7 |
| 2017 | 2 | 1 | 3 |
| 2018 | 5 | 2 | 7 |
| 2019 | 4 | 3 | 7 |
| 2020 | 2 | 1 | 3 |
| 2021 | 4 | 3 | 7 |
| 2022 | 0 | 3 | 3 |
| 2023 | 0 | 3 | 3 |
| 2024 | 2 | 5 | 7 |
| 2025 | 2 | 1 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Secondary Prevention" by people in Profiles.
-
Integrating secondary prevention of rheumatic heart disease into the primary healthcare system in Northern Uganda. BMJ Glob Health. 2025 Aug 22; 10(8).
-
Estimated Theoretical Benefit of Aggressive LDL Lowering in Patients With Symptomatic Intracranial Atherosclerosis. Neurology. 2025 Jul 08; 105(1):e213768.
-
Statin initiation and early stroke recurrence in the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke Trial (POINT) trial population. J Stroke Cerebrovasc Dis. 2025 Jul; 34(7):108349.
-
Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Male and Female Patients: A Secondary Analysis of the ADAPTABLE Randomized Clinical Trial. JAMA Cardiol. 2024 Sep 01; 9(9):808-816.
-
Impact of aspirin dose according to race in secondary prevention of atherosclerotic cardiovascular disease: a secondary analysis of the ADAPTABLE randomised controlled trial. BMJ Open. 2024 08 07; 14(8):e078197.
-
Efficacy and Safety of Bleselumab in Preventing the Recurrence of Primary Focal Segmental Glomerulosclerosis in Kidney Transplant Recipients: A Phase 2a, Randomized, Multicenter Study. Transplantation. 2024 08 01; 108(8):1782-1792.
-
Predictors of Shock-Reduction Programming and Its Impact on Implantable Cardioverter-Defibrillator Therapies and Mortality: The CERTITUDE Registry. J Am Heart Assoc. 2024 Aug 06; 13(15):e034500.
-
Age and Aspirin Dosing in Secondary Prevention of Atherosclerotic Cardiovascular Disease. J Am Heart Assoc. 2024 Feb 20; 13(4):e026921.
-
Relapse Rates With Paliperidone Palmitate in Adult Patients With Schizophrenia: Results for the 6-Month Formulation From an Open-label Extension Study Compared to Real-World Data for the 1-Month and 3-Month Formulations. Int J Neuropsychopharmacol. 2024 02 01; 27(2).
-
Randomized Secondary Prevention Trials in Participants With Symptomatic Intracranial Atherosclerotic Stenosis. Stroke. 2024 02; 55(2):324-334.